Des Moines, IA, March 23, 2012
Eurofins Scientific, Inc., (www.eurofinsus.com) the world leader in analytical support to the global agri-food market, announces the planned acquisition of the Quality Trait Analysis (QTA®) business (www.qta.com) of BASF Corporation, the world's leading chemical company with a portfolio ranging from chemicals, plastics, performance products, and agricultural products to oil and gas. The acquisition will strengthen Eurofins' growing presence in the US while adding a unique business possessing the most advanced expertise in on-site quality analysis systems.
The QTA® System is a patented analytical service that enables clients to quickly and easily test the quality of products and materials, reliably and accurately. QTA® handles all the technical development, configuration, management and monitoring behind the scenes, enabling accurate quality testing by non-technical personnel, and allowing its clients more freedom in managing their operations. With high quality data, obtained in rapid times, QTA® helps its clients measurably increase the value of their finished product, improve process yields, reduce waste and rework, and improve profitability. Its leading technology serves global stakeholders in multiple industry segments, including biodiesel, pesticides, seed and grain, chemicals, food ingredients, and dietary supplements.
As an integral component of this deal, Eurofins also will enter into a supplier agreement with BASF Corporation to provide QTA® patented testing and technical support to BASF globally.
The acquisition coupled with this global supplier agreement will allow QTA® to offer the full range of services available from Eurofins' collection of more than 160 laboratories around the world. Behind these expanded services will be a high level of IT capabilities and systems that will allow clients to have convenient access to their data online via secure data portals, 24 hours a day, 7 days a week.
"Eurofins Scientific is committed to providing the best laboratory services and client support to its customers and is dedicated to consistently providing the highest level of analytical testing technology available in the industry," says Dr. Michael Russell, CEO of Eurofins Scientific's US Food Division.
For more information, please visit www.eurofinsus.com or contact:
|Eurofins Scientific, Inc.
US Corporate Headquarters
2200 Rittenhouse Street, Suite 175
Des Moines, IA 50321
Notes for the editor:
Eurofins - a global leader in bio-analysis
Eurofins Scientific is the world leader in food and pharmaceutical products testing. It is also number one in the world in the field of environmental laboratory services and one of the global market leaders in agroscience, genomics and central laboratory services.
With over 10,000 staff in more than 160 laboratories across 32 countries, Eurofins offers a portfolio of over 100,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products. The Group provides its customers with high-quality services, accurate results in time and expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.
The shares of Eurofins Scientific are listed on the NYSE Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).
This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgement of Eurofins Scientific' management as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the data available to the Company as of the date of publication, but no guarantee can be made as to their validity.Information réglementée
Communiqués au titre de l'obligation d'information permanente :
- Activité de l'émetteur (acquisitions, cessions...) Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-27143-eurofins-qta_english.pdf © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
|EUROFINS SCIENTIF||Euronext Paris||415.15 (c)||-0.76%||15 140|